AllanTBombardMD

PubMed

• 347 citations
  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting
  Mathias Ehrich, Cosmin Deciu, Tricia Zwiefelhofer, John A. Tynan, Lesley Cagasan
  American Journal of Obstetrics and Gynecology. 2011-03-01
• 629 citations
  DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.
  Glenn E. Palomaki, Edward M. Kloza, Geralyn Lambert-Messerlian, James E. Haddow, Louis M. Neveux
  Genetics in Medicine. 2011-11-01
• 383 citations
  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study
  Glenn E. Palomaki, Cosmin Deciu, Edward M. Kloza, Geralyn Lambert-Messerlian, James E. Haddow
  Genetics in Medicine. 2012-02-02

Journal Articles

• Circulating cell free DNA testing: are some test failures informative?  
  Palomaki GE, Kloza EM, Lambert-Messerlian GM, van den Boom D, Ehrich M, Deciu C, Bombard AT, Haddow JE, Prenat Diagn, 1/8/2015
• Factors affecting levels of circulating cell-free DNA in maternal plasma and their implications for noninvasive prenatal testing  
  Kinnings S, Geis J, Almasri E, Wang T, Guan X, McCullough R, Bombard A, Saldivar J-S, Oeth P, Deciu C, Prenat Diagn, 1/1/2015
• Noninvasive prenatal testing for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing ...  
  Porreco RP, Garite TJ, Maurel K, Maruziak B, Ehrich M, van den Boom D, Deciu C, Bombard A, Am J Obstet Gynecol, 1/1/2014
• Non-Invasive prenatal chromosomal aneuploidy testing-Clinical Experience: >100,000 clinical samples  
  McCullough RM, Almasri EA, Guan X, Geis J, Mazloom AR, Kim SK, Deciu C, Oeth P, Bombard AT, Dharajiya N, Saldivar JS, PlosOne, 1/1/2014
• Comment on "Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixe...  
  Kim S, Zhao C, Bombard AT, Cantor C, van den Boom D, Deciu C, Prenat Diagn, 1/1/2013
• Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies  
  Lambert-Messerlian G, Kloza EM, Williams J, Loucky J, O/'Brien B, Wilkins-Haug L, Mahoney MJ, De Biasio P, Borrell A, Ehrich M, van den Boom D, Bombard AT, Deciu C, Pa..., Genet Med, 1/1/2013
• Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma  
  Mazloom A, Dzakula Z, Wang H, Oeth P, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard A, Maeder M, McLennan G, Meschino W, Palomaki G, ..., Prenat Diagn, 1/1/2013
• DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations  
  Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE, Prenat Diagn, 1/1/2012
• DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13, as well as Down syndrome: An international collaborative study  
  Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich, M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick, JA, Genet Med, 1/1/2012
• Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11-13 weeks of gestation  
  Akolekar R, Farkas DH, VanAgtmael AL, Bombard AT, Nicolaides KH, Prenat Diagn, 1/1/2010
• The Suitability of Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in a Laboratory Developed Test Using Cystic Fibrosis Carrier Screening ...  
  Farkas D, Miltgen NE, Stoerker J, van den Boom D, Highsmith EW, Cagasan L, McCullough R, Mueller R, Tang L, Tynan J, Rowell-Tate C, Bombard AT, J Molec Diagn, 1/1/2010
• A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios  
  Yan-Rosenberg L, Burt S, Bombard, A, Collado-Khoury F, Sharett L, Julliard, K, Weiner Z, The Journal of Maternal-Fetal & Neonatal Medicine, 1/1/2007
• Ob Team Stat: Developing a Better L&D Rapid Response Team  
  Catanzarite V, Almryde K, Bombard A, Contemp Ob/Gyn, 1/1/2007
• Characteristics of patients with abnormal glucose challenge test (GCT) and normal glucose tolerance test (OGTT): comparison with normal and gestational diabetic patients  
  Dudhbhai M, Lim L, Bombard A, Julliard K, Meenakshi B, Trachtenberg Y, Weiner Z, Am J Obstet Gynecol, 1/1/2006
• Correlation between intrapartum fetal heart rate pattern and umbilical cord arterial blood gases in low-risk patients  
  Weiner Z, Dudhbhai M, Bhillakar M, Bombard A, Am J Obstet Gynecol, 1/1/2005
• Ethnic variation of fetal nasal bone length between 11-14 weeks' gestation  
  Collado F, Bombard A, Li Vi, Julliard K, Aptekar L, and Weiner Z, Prenat Diagn, 1/1/2005
• Clinical and sonographic estimation of fetal weight performed by residents during the active phase of labor  
  Noumi G, Collado-Khoury F, Bombard AT, Julliard K, Weiner Z, Am J Obstet Gynecol, 1/1/2005
• Effect of maternal hydration on the AFI in women with oligohydramnios  
  Yan-Rosenberg L, Burt S, Collado-Khoury F, Sharet L, Bombard A, Weiner Z, Am J Obstet Gynecol, 1/1/2005
• Trisomy 9 screened positive for trisomy 18 maternal serum screening  
  Collado FK, Anderson V, Haas B, Fisher AJ, Bombard AT, Weiner Z, Prenat Diagn, 1/1/2004
• Counseling the Patient with Trisomy 17 Mosaicism Found at Genetic Amniocentesis  
  Collado FK, Fisher AJ, Bombard AT, Prenat Diagn, 1/1/2003
• Letter to the Editor: Insurance Justification Letters  
  Bombard AT, J Genet Coun, 1/1/2002
• Informed consent for maternal serum screening in an inner city population: How informed is it?  
  Freda MC, DeVore N, Valentine-Adams N, Bombard A, Merkatz IR, JOGNN, 1/1/1998
• Levels of urinary beta-core fragment, total estriol and the ratio of the two in second trimester screening for Down syndrome  
  Kellner LH, Canick JA, Palomaki GE, Neveaux LM, Saller DN, Walker RP, Osathanondh R, Bombard AT, Prenat Diagn, 1/1/1997
• Neutrophil alkaline phosphatase: Where do we go from here?  
  Kellner LH, Ferreira JCP, Bombard, AT, Proceedings of the International Conference: Down Syndrome Screening Policy and Economic Evaluation (Athens, Greece), 1/1/1997
• Urinary markers: A new approach to screening for Down syndrome in the second trimester  
  Kellner LH, Canick JA, Palomaki GE, Saller DN, Lambert-Messerlian GM, Neuer M, Osanthanondh R, Bombard AT, Am J Hum Genet, 1/1/1996
• Join now to see all

Books/Book Chapters

• Clin Obstet Gynecol 
  Chapter: Noninvasive prenatal detection of aneuploidy. 
  Page 210 - 225Robinson C, van den Boom D, Bombard AEditors: Scott, JR MD and Gabbe SG, Skupski, D MD (Guest Ed.).Wolters Kluwer/Lippincott Williams & Wilkins Publishers, Philadelphia, PA2014
• Clin Lab Med 
  Chapter: Prenatal Screening for Open Fetal Defects. 
  Page 385 - 394Canick J, Kellner LH and Bombard ATW. B. Saunders, Inc., Philadelphia, PA2003
• Complications of Pregnancy 
  Chapter: Teratogenic Drugs. 
  Ferreira JCP, Sachs GS, Bombard ATEditors: Parisi V and Cohen WR.JB Lippincott Company, Philadelphia, PAEdition 5th,1999
• Down Syndrome Screening Policy and Economic Evaluations; European Group for Down syndrome 
  Chapter: Neutrophil alkaline phosphatase: Where do we go from here? 
  Kellner LH, Ferreira J, Bombard ATEditors: Beazoglou T, Benn P, Cuckle H, Haddow J, and Kyriopolous J.National School of Public Health & Exandas Publishers, Athens, Greece1999
• Genetic Disorders and the Fetus: Diagnosis, Prevention, and Therapy 
  Chapter: Amniocentesis. 
  Elias S, Simpson, JL, Bombard ATEditors: Milunsky A.The Johns Hopkins University Press, BaltimoreEdition 4th,1998
• Obstetrics and Gynecology Clinics of North America 
  Chapter: Screening for the Aneuploid Fetus. 
  Gross SJ, Bombard ATEditors: Roberts WE and Perry K.WB Saunders Company, Philadelphia, PA1998
• Clin Obstet Gynecol 
  Chapter: The genetics of ovarian cancer: An assessment of current screening protocols and recommendations for counseling families at risk. 
  Bombard AT, Fields A, Aufox S, and Ben-Yishay MJB Lippincott Company, Philadelphia, PA1996
• Obstetrics and Gynecology Clinics of North America 
  Chapter: Reproductive genetics for couples over forty. 
  Page 279 - 297Bombard AT and Naef RWEditors: Barad, D.WB Saunders Company, Philadelphia, PA1993
• Spon-taneous Abortion 
  Chapter: Chromosomal abnormalities in spontaneous abortions: Frequency, pathology, and genetic counseling 
  Simpson JL and Bombard ATEditors: Edmonds, DK and Bennett, MJ.William Heineman Medical Books, London1987
• Join now to see all

Abstracts/Posters

• Whole-genome maternal plasma DNA sequencing for fetal aneuploidy accurately detects autosomal and sex chromosome abnormalities: An Internal Validation Study with Indep...
  Tarrier B, Mann T, Kim J, Clos L, Sekedat M, Stoerker J, Bombard A, International Society of Prenatal Diagnosis Annual Meeting, Washington, DC, 1/1/2015
• A case of maternal malignancy diagnosed following a quadruple aneuploidy NIPT result.
  Settler C, Dohany L, Manthei E, Chaperon J, Bombard A, American College of Medical Genetics Annual Meeting, Salt Lake City, UT, 1/1/2015
• Implementation of pharmacogenetic testing for anti-depressant and anti-psychotic medication into the Obstetrician/Gynecologist practice.
  Dohany L, Stoerker J, DaRae J, Chaperon J, Settler C, Bombard A, Buis J, American College of Medical Genetics Annual Meeting, Salt Lake City, UT, 1/1/2015
• Routine carrier screening in a clinical laboratory: A case series of unexpected results.
  Chaperon J, Dohany L, Settler C, Holland C, Stoerker J, DaRae J, Bombard A, Weindel, M, American College of Medical Genetics Annual Meeting, Salt Lake City, UT, 1/1/2015
• Noninvasive prenatal chromosomal aneuploidy testing: 100,000 patients-Clinical Samples.
  McCullough RM, Almasri E, Guan X, Oeth P, Bombard AT, Saldivar JS, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Annual Meeting, New Orleans, LA, 1/1/2014
• 2013 SMFM Professional Liability Survey by the Society for Maternal Fetal Medicine Risk Management Committee.
  Amon E, Cohen A, Bronsky G, Bombard A, Eglinton G, Hill W, McLean D, Neubert AG, Parer J, Phelan J, Strassner H, Stiller R, Yankowitz J, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Annual Meeting, New Orleans, LA, 1/1/2014
• 2013 SMFM Professional Quality Management Survey by the Society for Maternal Fetal Medicine Risk Management Committee.
  Amon E, Cohen A, Bronsky G, Bombard A, Eglinton G, Hill W, McLean D, Neubert AG, Parer J, Phelan J, Strassner H, Stiller R, Yankowitz J, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Annual Meeting, New Orleans, LA, 1/1/2014
• Fetal fraction in noninvasive prenatal testing (NIPT) for multiple gestations.
  Geis J, Kinnings S, Almasri E, Wang H, Guan X, McCullough R, Saldivar J-S, Bombard A, Oeth P, Deciu C, American College of Medical Genetics Annual Meeting, Nashville, TN, 1/1/2014
• Factors affecting levels of circulating cell-free DNA in maternal plasma and their implications for noninvasive prenatal testing.
  Kinnings S, Geis J, Almasri E, Wang T, Guan X, McCullough R, Bombard A, Saldivar J-S, Oeth P, Deciu C, American College of Medical Genetics Annual Meeting, Nashville, TN, 1/1/2014
• Factors affecting levels of circulating cell-free DNA in maternal plasma and their implications for noninvasive prenatal testing.
  Kinnings S, Geis J, Almasri E, Wang T, Guan X, McCullough R, Bombard A, Saldivar J-S, Oeth P, Deciu C, International Society of Prenatal Diagnosis Annual Meeting, 1/1/2014
• Disomic placentas, Trisomic babies: Reverse mosaicism and implications for non-invasive prenatal testing (NIPT).
  Boomer T, Dharajiya N, Paxton WB, Bombard AT, Noonan CW, Hoppman NL, Highsmith EW, Wick M, Saldivar JS, National Society of Genetic Counseling Annual Meeting, 1/1/2014
• Noninvasive prenatal testing (NIPT) in a low-risk population: A blinded prospective study with birth outcome.
  Bombard AT, Almasari E, McCullough RM, Crabb R, McLennan G, Moellering S, Casagan L, Monroe T, Oeth P, Saldivar JS, Am Coll Obstet Gynecol Districts V, VI, VIII, IX Annual Meeting, Wailea, HI, 1/1/2013
• Factors affecting circulating cell-free fetal DNA for noninvasive prenatal testing (NIPT).
  McCullough RM, Saldivar JS, Geis JA, Hicks SC, Bombard AT, Am Coll Obstet Gynecol Annual Clinical Meeting, New Orleans, LA, 1/1/2013
• Noninvasive prenatal testing (NIPT) in multiple gestations: A report of laboratory experience.
  Bombard AT, McCullough RM, Hicks SC, Geis JA, Almasari E, Saldivar JS, Am Coll Obstet Gynecol Annual Clinical Meeting, New Orleans, LA, 1/1/2013
• Noninvasive prenatal testing (NIPT) using the MaterniT21 PLUS test: The clinical experience.
  Saldivar JS, McCullough RM, Hicks S, Oeth P, Bombard AT, American College of Medical Genetics Annual Clinical Meeting, Phoenix, AZ, 1/1/2013
• Superior Pan-Ethnic Population Carrier Screening for Mutations that Cause Cystic Fibrosis.
  Farkas, DH, Stoerker J, Tynan, J, Highsmith EW, Mueller, R, Bombard, A, Annual Meeting of the American Congress of Obstetricians and Gynecologists, San Francisco, CA, 1/1/2010
• Single reaction molecular assay for noninvasive prenatal RHD genotyping and sex determination using circulating cell-free fetal nucleic acids.
  Paladino T, Stoerker J, Bombard A, Van den Boom D, Oeth P, Annual Meeting of the American College of Medical Genetics, Albuquerque, NM, 1/1/2010
• Non-invasive prenatal testing: Technical strategies to achieve testing of cell free fetal DNA (cFFDNA) RhD genotype in a clinical lab.
  Brown S, Kellner L, Munson M, Yang Y, Klotzle B, Bombard A, Am J Obstet Gynecol, 1/1/2007
• Fetal cardiac scanning performed immediately following an abnormal NT examination.
  Weiner Z, Weizman B, Goldstein I, Beloosesky R, Bombard A, Am J Obstet Gynecol, 1/1/2007
• Preventing needlestick injuries in obstetrics and gynecology: Assessing the penetration of blunt tip needles into practice.
  Catanzarite V, Byrd K, McNamara M, Bombard A, Proceedings of the 44th Annual ACOG Armed Forces District Meeting, Sonthofen, Germany, 1/1/2006
• Pregnancy outcome in patients with abnormal glucose challenge test and normal oral glucose tolerance test: Comparison with normal and gestational diabetic patients.
  Dudhbhai M, Fisher A, Bombard A, Julliard K, Weiner Z, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Meeting, 1/1/2005
• Clinical and sonographic estimation of fetal weight performed by residents during the active phase of labor.
  Noumi G, Venegas J, Bombard A, Weiner Z, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Meeting, 1/1/2005
• Ethnic variation of fetal nasal bone length between 11-14 weeks' gestation.
  Collado F, Bombard A, Li V, Julliard K, Weiner Z, Am J Obstet Gynecol, Society of Maternal-Fetal Medicine Meeting, 1/1/2005
• Correlation between intrapartum fetal heart rate pattern and umbilical cord arterial blood gases in low-risk patients.
  Weiner Z, Dudhbhai M, Bhillakar M, Bombard A, Am J Obstet Gynecol, 1/1/2005
• Effect of maternal hydration on the AFI in women with oligohydramnios.
  Yan-Rosenberg L, Burt S, Collado-Khoury F, Sharet L, Bombard A, Weiner Z, Am J Obstet Gynecol, 1/1/2005
• Join now to see all

Lectures

• Noninvasive prenatal diagnosis-Closing the Gaps: Are we ready to accept NIPT in clinical practice. 
  Istanbul, Turkey - 1/1/2013
• Circulating Cell-Free (ccf) Nucleic Acid Technology: The Evolution of Prenatal Diagnosis. 
  Honolulu, HI - 1/1/2013
• Transitioning New Technologies from the Bench to the Bedside: Direct Fetal Testing Using Circulating Cell-Free DNA. 
  San Francisco, CA - 1/1/2013
• Circulating Cell-Free (ccf) Nucleic Acid Technology: The Evolution of Prenatal Diagnosis for Fetal Aneuploidy. 
  Boston, MA - 1/1/2011
• Noninvasive Prenatal Diagnosis in Contemporary Obstetric Practice. 
  Rochester, MN - 1/1/2011
• Clinical Applications of Mass Spectrometry in Prenatal Health Care. 
  Phoenix, AZ - 1/1/2010
• Clinical applications of mass spectrometry in prenatal healthcare. 
  Dallas, TX - 1/1/2010
• "Health insurance and the provision of genetics services." 
  San Diego, CA - 1/1/2006
• "Predictive Genetic Testing: The Managed Care Perspective" 
  New York, NY - 1/1/2004
• "First and Second Trimester Screening for Down Syndrome." 
  Brooklyn, NY - 1/1/2004
• "ACGME Competencies-Resident Training in Practice-Based Learning and Systems-Based Practice: Fundamentals of Healthcare Financing." 
  Brooklyn, NY - 1/1/2004
• Screening for Genetic Diseases and The Business of Health Care. 
  Chattanooga, TN - 1/1/2003
• Genetics & Prenatal Diagnosis. 
  Brooklyn, NY - 1/1/2003
• The Role of the Medical Director in Health Plans. Insurance 101: Financing Health Care. Insurance 102: Effecting Change. 
  New Orleans, LA - 1/1/2003
• Genetic Screening in Contemporary Obstetric Practice. 
  Staten Island, NY - 1/1/2003
• Genetic Testing and Reproductive Decisionmaking: Financial Considerations. 
  Washington, DC - 1/1/2003
• Understanding Managed Care-"Insurance 101." 
  Brooklyn, NY - 1/1/2002
• Genetic Screening: When, What, and How 
  Toronto, ON - 1/1/2002
• Down Syndrome Screening: First or Second Trimester: How and Who? 
  Toronto, ON - 1/1/2002
• Genetic Screening. 
  New Orleans, LA - 1/1/2002
• Genetics and Health Insurance. 
  Chicago, IL - 1/1/2001
• The Business of Medicine: Survival After Your Residency. 
  Bronx, NY - 1/1/2001
• What Can We Expect of Genetic Medicine? What Health Plans Need to Know-Benefit Design/Coverage Considerations. 
  Los Angeles, CA - 1/1/2001
• Understanding (and Navigating) the Health Insurance Industry. 
  Chicago, IL - 1/1/2001
• Genetic Privacy: Legal and Ethical Frameworks. 
  Harvard Law School, Cambridge, MA - 1/1/2001
• Join now to see all

Other

• Ob Team Stat: Rapid response to obstetrical emergencies. 
  Clements CJ, Flohr-Rincon S, Bombard AT, Catanzarite V, Nursing for Women's Health (AWHONN)
  1/1/2007
• Indications for use: Prenatal Diagnosis 
  Bombard AT, Determining the utility of clinical tests-NCCLS Guideline
  1/1/2004
• Privacy and Preventive Health Care: Integrating Coverage of Genetic Technologies into Health Care Policies. 
  Bombard A, Cohen AW, Harvard Health Caucus: Working Paper Series, The Social Implications of the Human Genome Project
  http://web.med.harvard.edu/healthcaucus/
  1/1/2002
• Prenatal screening for fetal Down syndrome. 
  Venegas G, Khoury E, Bombard AT, Women's Health Advances Today magazine (American Association of Health Plans publication)
  1/1/2002
• Genetic Breast Cancer Susceptibility Testing. 
  Armstrong J, Bombard AT, "Women's Health Advances Today: Breast Cancer", Am Assoc Health Plans
  1/1/2001
• Coverage of Preconceptional Sex Selection Techniques. 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin #323
  1/1/1999
• Genetic Testing. 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin #140
  1/1/1999
• Down syndrome screening by ultrasonographic assessment of fetal nuchal thickening (NT). 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin #282
  1/1/1999
• Coverage of Preimplantation Genetic Testing. 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin
  1/1/1999
• Coverage of Prenatal Diagnosis for Fetal Genetic Disease. 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin
  1/1/1999
• Management of Women at Risk for Breast Cancer (BRCA Testing, Prophylactic Mastectomy, Tamoxifen). 
  Leibowitz A, Cohen AW, Bombard AT, Aetna U.S. Healthcare Coverage Policy Bulletin #227
  1/1/1998
• Re-engineering the academic medical center: Reproductive genetics as a model for implementing consumer-focused services. 
  Bombard AT, Kellner LH, Kapel AS, Brown MA, Merkatz IR, Nitowsky HM, GENES Newsletter
  1/1/1997
• CVS versus Amniocentesis. 
  Weinbaum PJ, Bombard AT, Phillips OP, ACOG Update
  1/1/1994
• The Strategic Air and Sea Campaign Against Japan During World War II, 1942-1945. 
  Bombard, AT, Air War College Study Project
  Air University, Maxwell Air Force Base, AL - 1/1/1994
• Clinical perspectives on neural tube defects. 
  Bombard AT, Med Bull PB
  1/1/1989
• Join now to see all